Practice of Medication Therapy Management for A Patient with Obesity Diabetes Mellitus by Clinical Pharmacists
- VernacularTitle:临床药师对1例肥胖型糖尿病患者开展药物治疗管理的实践
- Author:
Huan XIONG
1
;
Xingwei WU
2
;
Xirui GUO
1
;
Xiangzun XIONG
1
;
Jiaying ZHANG
1
;
Enwu LONG
2
Author Information
1. Medical College，University of Electronic Science and Technology of China，Chengdu 610054，China
2. Dept. of Pharmacy，the Affiliated Hospital of University of Electronic Science and Technology/Sichuan Provincial People’s Hospital，Chengdu 610072，China
- Publication Type:Journal Article
- Keywords:
Medication therapy management;
Obesity diabetes mellitus;
Clinical pharmacists;
Practice
- From:
China Pharmacy
2019;30(13):1830-1834
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE： To explore the role of clinical pharmacists in medication therapy management （MTM）. METHODS： Referring to the practice model of MTM in the United States， taking a noninfectious chronic disease （obesity diabetes mellitus） patient as an example， clinical pharmacists of endocrinology specialty carried out MTM according to five processes， such as patient information collection， medication therapy review， the formulation of medication-related action plan （MRP）， interventions related to direct communication with physicians or advising patients to consult relevant medical service personnel， record and follow-up. RESULTS： The information of patients collected by clinical pharmacists included past medical history， family history， allergy history and medication history， etc. It was the top priority MRP for this patient to identify inappropriate hypoglycemic drug therapy， obesity-induced obstructive sleep apnea-hypopnea syndrome and hyperlipidemia. For obesity patients with type 2 diabetes mellitus， clinical pharmacists recommend that patients changed insulin drugs to non-insulin drugs， and liraglutide was recommended. In view of the poor control of blood lipid level， fenofibrate was recommended for patients on the basis of oral administration of simvastatin. The patient’s attending physician agreed with the above suggestion and adjusted the prescription. Clinical pharmacists provided medication education for the patients about the importance of each drug， control of total energy intake， balanced diet and physical exercise. The follow-up results after 6 months showed that blood glucose （fasting blood glucose 5-7 mmol/L， postprandial blood glucose 8-10 mmol/L） and blood lipid （total cholesterol 4.80 mmol/L， triglyceride 1.60 mmol/L， low density lipoprotein 3.05 mmol/L） of the patient were effectively controlled and body weight was reduced by 3 kg， but the improvement of lifestyle was poor， mainly due to the nature of his work. Clinical pharmacists once again communicated with him and emphasized the importance of proper physical exercise. The patients agreed to continue the follow-up. CONCLUSIONS： Clinical pharmacists can provide professional consultation and service for patients with chronic diseases by means of MTM service mode， which has certain value for improving medical quality.
